Masahiro Shiroo
- Molecular Biology top 10%
- Immunology top 5%
- Oncology top 10%
- Cancer Research top 10%
- Immunology and Allergy top 5%
- Co-authors
- Koji MatsushimaNaofumi MukaidaShunsuke MigitaMark BiffenDenis R. AlexanderTimothy ChambersKatsuko SuharaLindsey K. Goff
- Topics
- T-cell and B-cell Immunology (4 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers)Glycosylation and Glycoproteins Research (3 papers)
- Partner nations
- United KingdomJapanSlovakia
In The Last Decade
Masahiro Shiroo
24 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 709
- Immunology 564
- Oncology 378
- Cancer Research 195
- Immunology and Allergy 148
Countries citing papers authored by Masahiro Shiroo
This map shows the geographic impact of Masahiro Shiroo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Shiroo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Shiroo more than expected).
Fields of papers citing papers by Masahiro Shiroo
This network shows the impact of papers produced by Masahiro Shiroo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Shiroo. The network helps show where Masahiro Shiroo may publish in the future.
Co-authorship network of co-authors of Masahiro Shiroo
This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Shiroo. A scholar is included among the top collaborators of Masahiro Shiroo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Shiroo. Masahiro Shiroo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 98 | |
| 2 | 11 | |
| 3 | Recent developments in cathepsin K inhibitor design. | 55 |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 45 | |
| 7 | 21 | |
| 8 | 7 | |
| 9 | 56 | |
| 10 | 44 | |
| 11 | 18 | |
| 12 | 158 | |
| 13 | 39 | |
| 14 | The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A. | 34 |
| 15 | 69 | |
| 16 | 1 | |
| 17 | 59 | |
| 18 | 42 | |
| 19 | 52 | |
| 20 | 53 |
About Masahiro Shiroo
Masahiro Shiroo is a scholar working on Immunology and Allergy, Oncology and Pharmacology, having authored 24 papers that have together received 1.4k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Immunology (564 citations), Immunology and Allergy (148 citations) and Oncology (378 citations). Masahiro Shiroo has collaborated with scholars based in United Kingdom, Japan and Slovakia. Frequent co-authors include Koji Matsushima, Naofumi Mukaida, Shunsuke Migita, Mark Biffen, Denis R. Alexander, Timothy Chambers, Katsuko Suhara, Lindsey K. Goff, Jeremy Saklatvala and Ei Kawahara. Their work appears in journals such as Science, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.